ConforMIS, which sells fully customized knee replacement implants, raised $135 million by offering 9 million shares at $15, the midpoint of the range of $14 to $16. ConforMIS plans to list on the NASDAQ under the symbol CFMS. ConforMIS initially filed confidentially on 3/20/2015. J.P. Morgan and Deutsche Bank acted as lead managers on the deal.
